Race Oncology Health Care
Cancer Chemotherapy Imaging Medical Radiology

$1.23 -0.02 (-1.21%)

High $1.29	Low $1.18	Trades 155	Turnover $303,224	Volume 249,053
30 June 2023 at 4:10pm

Market Cap (4-Aug) $385,275,488 (417th)	Close (30-Jun) $1.23 0 (0%)	Volume (30-Jun) 249,053	Shortsold (29-Jul) 19,354 (0.01%) (572nd)
52w High $4.90	52w Low $1.14	P/E -	EPS -0.05

Short Interest

ASIC data, 29 Jul 2026

% Shorted

0.01%

vs 0.01% prior report

Most Shorted Rank

572nd

of 717 shorted ASX stocks

Peak Short

0.05%

Dec 2021

Days to Cover

0.2

at 50d avg vol

View full short position history →

	Subject
	RAC RAC Ann: Notification of cessation of securities - RAC
	1 (current) 2 3
	RAC RAC Ann: Proposed issue of securities - RAC
	RAC RAC Ann: Initial Director's Interest Notice
	RAC RAC Ann: Final Director's Interest Notice
	RAC RAC Ann: Race Board Changes
	RAC RAC Ann: Update - Notification of buy-back - RAC
	RAC RAC Ann: Race Completes On-Market Buy-Back Program
	RAC RAC Ann: Letter to Shareholders
	RAC RAC Ann: Ceasing to be a substantial holder
	RAC RAC Ann: Cleansing Notice
	RAC RAC Ann: Application for quotation of securities - RAC
	RAC RAC Ann: Race appoints Dr Michelle Rashford Chief Medical Officer
	RAC RAC Ann: Quarterly Activity Report & Appendix 4C
	RAC RAC Ann: Race continues Board renewal - appoints new Chair
	RAC RAC Ann: Race releases complete cardio-protection data & video
	RAC RAC Ann: Race releases cardioprotection market potential data
	RAC RAC Ann: Race Receives $1.48m R&D Tax Refund for Financial Year 2022
	RAC RAC Ann: Final Director's Interest Notice - Dr Daniel Tillett
	RAC RAC Ann: Race Leadership Changes
	RAC RAC Ann: Trading Halt
	RAC RAC Ann: Pause in Trading
	RAC RAC Ann: Race Executes Contracts to Commence Breast Cancer Trial
	RAC RAC Ann: Replacement Appendix 3Y - Damian Clarke Bruce
	RAC RAC Ann: Appendix 3Y x 3
	RAC RAC Ann: Notification regarding unquoted securities - RAC
	RAC RAC Ann: New Collaboration to Understand Zantrene Cardioprotection
	RAC RAC Ann: Appendix 4D & Half-Year Financial Statements
	RAC RAC Ann: Results of Meeting
	RAC RAC Ann: Appendix 3Y - Dr Daniel Tillett
	RAC RAC Ann: Cleansing Notice
	RAC RAC Ann: Application for quotation of securities - RAC
	RAC RAC Ann: Replacement Appendix 3X - Damian Clarke-Bruce
	RAC RAC Ann: Race Receives Cardioprotection Ethics Trial Approval
	RAC RAC Ann: Appendix 3X - Damian Clarke-Bruce
	RAC RAC Ann: Quarterly Activity Report & Appendix 4C
	RAC RAC Ann: Letter to Shareholders, Notice of Meeting & Proxy Form
	RAC RAC Ann: Appendix 3Y - Dr Daniel Tillett
	RAC RAC Ann: December 2022 Preclinical & Clinical Programs Update
	RAC RAC Ann: Race supports Study of Extramedullary AML
	RAC RAC Ann: Appendix 3Y - Dr Daniel Tillett
	RAC RAC Ann: Proposed issue of securities - RAC
	RAC RAC Ann: Race Appoints Damian Clarke-Bruce as CEO & Managing Director
	RAC RAC Ann: Ethics submission to commence cardioprotection trial
	RAC RAC Ann: Appendix 3X - Danny Sharp
	RAC RAC Ann: Proposed issue of securities - RAC
	RAC RAC Ann: Danny Sharp appointed Independent Non-Executive Director
	RAC RAC Ann: Constitution
	RAC RAC Ann: Results of Annual General Meeting
	RAC RAC Ann: Race 2022 AGM Presentations
	RAC RAC Ann: Positive Pre-IND Guidance from FDA on Zantrene

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
04-Aug	$1.97	121,750	+0.02 (0.77%)
03-Aug	$1.95	109,946	0.00 (0.00%)
31-Jul	$1.95	80,649	+0.02 (1.04%)
30-Jul	$1.93	129,057	-0.06 (3.02%)
29-Jul	$1.99	149,816	-0.05 (2.45%)
28-Jul	$2.04	49,460	-0.03 (1.45%)
27-Jul	$2.07	42,130	+0.02 (0.98%)
24-Jul	$2.05	44,444	0.00 (0.00%)
23-Jul	$2.05	73,714	0.00 (0.00%)
22-Jul	$2.05	94,292	+0.01 (0.49%)
21-Jul	$2.04	87,502	+0.04 (2.00%)
20-Jul	$2.00	92,443	-0.13 (6.10%)
17-Jul	$2.13	89,546	-0.44 (17.12%)
18-Sep	$2.57	834,409	+0.96 (59.63%)
12-Sep	$1.61	161,062	+0.03 (1.58%)
7 up, 5 down, and 3 flat days

Race Oncology Health Care
Cancer Chemotherapy Imaging Medical Radiology

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Race Oncology Health Care Cancer Chemotherapy Imaging Medical Radiology

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Race Oncology Health Care
Cancer Chemotherapy Imaging Medical Radiology